Implication of heme oxygenase-1 in the sensitivity of nasopharyngeal carcinomas to radiotherapy

Journal of Experimental and Clinical Cancer Research

Volumn 27, Issue 1, 2008, Pages

  Shi, Lei ^a   Fang, Jun ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b SOJO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEME OXYGENASE 1; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT RESPONSE; TUMOR REGRESSION; TUMOR VOLUME; CARCINOMA; GENETICS; METABOLISM; MIDDLE AGED; NASOPHARYNX; NASOPHARYNX TUMOR; PATHOLOGY; RADIATION DOSE; RADIATION EXPOSURE;

ADULT; AGED; CARCINOMA; HEME OXYGENASE-1; HUMANS; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NASOPHARYNX; RADIOTHERAPY DOSAGE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 52949129507     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-27-13     Document Type: Article

References (27)

1. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. MD Maines, FASEB J 1988 2 2557 2568 3290025
2. Regulation of heme oxygenase gene expression. S Shibahara, Semin Hematol 1988 25 370 376 3064317
3. Endothelial heme oxygenase-1 induction by hypoxia. Modulation by inducible nitric oxide synthase and S-nitrosothiols. R Motterlini R Foresti R Bassi V Calabrese JE Clark CJ Green, J Biol Chem 2000 275 13613 13620 10.1074/jbc.275.18.13613 10788478
4. The role of inorganic metals and metalloporphyrins in the induction of haem oxygenase and heat-shock protein 70 in human hepatoma cells. K Mitani H Fujita Y Fukuda A Kappas S Sassa, Biochem J 1993 290 819 825 8384446
5. Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenate. SM Keyse RM Tyrrell, Proc Natl Acad Sci USA 1989 86 99 103 2911585 10.1073/pnas.86.1.99
6. Induction of heme oxygenase-1 as a response in sensing the signals evoked by distinct nitric oxide donors. E Hara K Takahashi K Takeda, Biochem Pharmacol 1999 58 227 236 10.1016/S0006-2952(99)00097-0 10423162
7. Regulation of heme oxygenase-1 gene expression in vascular smooth muscle cells by nitric oxide. SL Hartsfield J Alam JL Cook AMK Choi, Am J Physiol 1997 273 L980 988 9374724
8. Pro-oxidant and cytotoxic effects of circulating heme. V Jeney J Balla A Yachie, Blood 2002 100 879 887 10.1182/blood.V100.3.879 12130498
9. Biliverdin reductase: a major physiologic cytoprotectant. DE Baranano M Rao CD Ferris SH Snyder, Proc Natl Acad Sci USA 2002 99 16093 16098 12456881 10.1073/pnas.252626999
10. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. S Brouard LE Otterbein J Anrather, J Exp Med 2000 192 1015 1025 11015442 10.1084/jem.192.7.1015
11. Ferritin: a cytoprotective antioxidant strategem of endothelium. G Balla HS Jacob J Balla, J Biol Chem 1992 267 18148 18153 1517245
12. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. TS Lee LY Chau, Nat Med 2002 8 240 246 10.1038/nm0302-240 11875494
13. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. K Sato J Balla L Otterbein, J Immunol 2001 166 4185 4196 11238670
14. Heme oxygenase-1 attenuates ischemia/reperfusion-induced apoptosis and improves survival in rat renal allografts. M Wagner P Cadetg R Ruf L Mazzucchelli P Ferrari CA Redaelli, Kidney Int 2003 63 1564 1573 10.1046/j.1523-1755.2003.00897.x 12631374
15. Induction of heme oxygenase in toxic renal injury: a protective role in cisplatin nephrotoxicity in the rat. A Agarwal J Balla J Alam AJ Croatt KA Nath, Kidney Int 1995 48 1298 1307 10.1038/ki.1995.414 8569092
16. Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1. SG Tullius M Nieminen-Kelha R Buelow, Transplantation 2002 74 591 598 10.1097/00007890-200209150-00001 12352873
17. Antiapoptotic role of heme oxygenase (HO) and the potential of HO as a target in anticancer treatment. J Fang T Akaike H Maeda, Apoptosis 2004 9 27 35 10.1023/B:APPT.0000012119.83734.4e 14739596
18. Overexpression of the heme oxygenase gene in renal cell carcinoma. AI Goodman M Choudhury JL da Silva ML Schwartzman NG Abraham, Proc Soc Exp Biol Med 1997 214 54 61 9012361
19. Expression of heme oxygenase-1 (HSP32) in human prostate: normal, hyperplastic, and tumor tissue distribution. MD Maines PA Abrahamsson, Urology 1996 47 727 733 10.1016/S0090-4295(96)00010-6 8650873
20. International Union Against Cancer. P Hermanek LH Sobin, TUM Classification of Malignant Tumor 4th fully revised edition Berlin, Heidelberg, Springer Verlag 1987
21. Quantitation of heme oxygenase (HO-1) copies in human tissues by competitive RT/PCR. NG Abraham, Methods of Molecular Biology Totowa, NJ: Human Press, Armstrong D, 1998 199 209
22. Induction of haem oxygenase-1 by nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth. K Doi T Akaike S Fujii, Br J Cancer 1999 80 1945 1954 10.1038/sj.bjc.6690624 10471043
23. Antiapoptotic effect of haem oxygenase-1 induced by nitric oxide in experimental solid tumour. S Tanaka T Akaike J Fang, Br J Cancer 2003 88 902 909 10.1038/sj.bjc.6600830 12644828
24. In vivo antitumor activity of pegylated zinc protoporphyrin: targeted inhibition of heme oxygenase in solid tumor. J Fang T Sawa T Akaike, Cancer Res 2003 63 3567 3574 12839943
25. Heme oxygenase-1 expression in oral squamous cell carcinoma as involved in lymph node metastasis. MH Tsuji T Yanagawa S Iwasa, Cancer Lett 1999 138 53 59 10.1016/S0304-3835(98)00372-3 10378773
26. Pegylated zinc protoporphyrin: a water-soluble heme oxygenase inhibitor with tumor-targeting capacity. SK Sahoo T Sawa J Fang, Bioconjug Chem 2002 13 1031 1038 10.1021/bc020010k 12236785
27. Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin. J Fang T Sawa T Akaike K Griesh H Maeda, Int J Cancer 2004 109 1 8 10.1002/ijc.11644 14735461